{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T02:27:39Z","timestamp":1793845659532,"version":"4.6.1"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mol Med"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.2119\/molmed.2013.00164","type":"journal-article","created":{"date-parts":[[2014,3,27]],"date-time":"2014-03-27T17:30:16Z","timestamp":1395941416000},"page":"138-146","source":"Crossref","is-referenced-by-count":329,"title":["The Role of HMGB1 in the Pathogenesis of Inflammatory and Autoimmune Diseases"],"prefix":"10.1186","volume":"20","author":[{"given":"Melinda","family":"Magna","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David S.","family":"Pisetsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,2,6]]},"reference":[{"key":"2001138_CR1","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1146\/annurev-immunol-030409-101323","volume":"29","author":"U Andersson","year":"2011","unstructured":"Andersson U, Tracey KJ. (2011) HMGB1 is a therapeutic target for sterile inflammation and infection. Annu. Rev. Immunol. 29:139\u201362.","journal-title":"Annu. Rev. Immunol."},{"key":"2001138_CR2","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1038\/nrrheum.2011.222","volume":"8","author":"HE Harris","year":"2012","unstructured":"Harris HE, Andersson U, Pisetsky DS. (2012) HMGB1: a multifunctional alarmin driving autoimmune and inflammatory disease. Nat. Rev. Rheumatol. 8:195\u2013202.","journal-title":"Nat. Rev. Rheumatol"},{"key":"2001138_CR3","first-page":"856","volume":"93","author":"H Yang","year":"2013","unstructured":"Yang H, Antoine DJ, Andersson U, Tracey KJ. (2013) The many faces of HMGB1: a molecular structure-functional activity in inflammation, apoptosis, and chemotaxis. J. Leukoc. Biol. 93:856\u201373.","journal-title":"J. Leukoc. Biol."},{"key":"2001138_CR4","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.bbagrm.2009.11.003","volume":"1799","author":"U Andersson","year":"2010","unstructured":"Andersson U, Harris HE. (2010) The role of HMGB1 in the pathogenesis of rheumatic disease. Biochim. Biophys. Acta. 1799:141\u20138.","journal-title":"Biochim. Biophys. Acta."},{"key":"2001138_CR5","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1126\/science.285.5425.248","volume":"285","author":"H Wang","year":"1999","unstructured":"Wang H, et al. (1999) HMG-1 as a late mediator of endotoxin lethality in mice. Science. 285:248\u201351.","journal-title":"Science"},{"key":"2001138_CR6","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1002\/art.11028","volume":"48","author":"R Pullerits","year":"2003","unstructured":"Pullerits R, et al. (2003) High mobility group box chromosomal protein 1, a DNA binding cytokine, induces arthritis. Arthritis Rheum. 48:1693\u2013700.","journal-title":"Arthritis Rheum."},{"key":"2001138_CR7","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1002\/art.10859","volume":"48","author":"N Taniguchi","year":"2003","unstructured":"Taniguchi N, et al. (2003) High mobility group box chromosomal protein 1 plays a role in the pathogenesis of rheumatoid arthritis as a novel cytokine. Arthritis Rheum. 48:971\u201381.","journal-title":"Arthritis Rheum."},{"key":"2001138_CR8","doi-asserted-by":"publisher","first-page":"2052","DOI":"10.1002\/art.11161","volume":"48","author":"R Kokkola","year":"2003","unstructured":"Kokkola R, et al. (2003) Successful treatment of collagen-induced arthritis in mice and rats by targeting extracellular high mobility group box chromosomal protein 1 activity. Arthritis Rheum. 48:2052\u20138.","journal-title":"Arthritis Rheum."},{"key":"2001138_CR9","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1002\/art.20220","volume":"50","author":"AK Ulfgren","year":"2004","unstructured":"Ulfgren AK, et al. (2004) Down-regulation of the aberrant expression of the inflammation mediator high mobility group box chromosomal protein 1 in muscle tissue of patients with polymyositis and dermatomyositis treated with corticosteroids. Arthritis Rheum. 50:1586\u201394.","journal-title":"Arthritis Rheum."},{"key":"2001138_CR10","doi-asserted-by":"publisher","first-page":"3639","DOI":"10.1002\/art.21398","volume":"52","author":"K Popovic","year":"2005","unstructured":"Popovic K, et al. (2005) Increased expression of the novel proinflammatory cytokine high mobility group box chromosomal protein 1 in skin lesions of patients with lupus erythematosus. Arthritis Rheum. 52:3639\u201345.","journal-title":"Arthritis Rheum."},{"key":"2001138_CR11","doi-asserted-by":"publisher","first-page":"2289","DOI":"10.1002\/art.21969","volume":"54","author":"M Ek","year":"2006","unstructured":"Ek M, Popovic K, Harris HE, Naucl\u00e9r CS, Wahren-Herlenius M. (2006) Increased extracellular levels of the novel proinflammatory cytokine high mobility group box chromosomal protein 1 in minor salivary glands of patients with Sj\u00f6gren\u2019s syndrome. Arthritis Rheum. 54:2289\u201394.","journal-title":"Arthritis Rheum."},{"key":"2001138_CR12","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1096\/fj.09-144782","volume":"24","author":"C Grundtman","year":"2010","unstructured":"Grundtman C, et al. (2010) Effects of HMGB1 on in vitro responses of isolated muscle fibers and functional aspects in skeletal muscles of idiopathic inflammatory myopathies. FASEB J. 24:570\u20138.","journal-title":"FASEB J."},{"key":"2001138_CR13","doi-asserted-by":"publisher","first-page":"697","DOI":"10.3346\/jkms.2011.26.5.697","volume":"26","author":"JK Ahn","year":"2011","unstructured":"Ahn JK, Cha HS, Bae EK, Lee J, Koh EM. (2011) Extracellular high-mobility group box 1 is increased in patients with Behcet\u2019s disease with intestinal involvement. J. Korean Med. Sci. 26:697\u2013700.","journal-title":"J. Korean Med. Sci."},{"key":"2001138_CR14","doi-asserted-by":"publisher","first-page":"e29318","DOI":"10.1371\/journal.pone.0029318","volume":"6","author":"I Mitroulis","year":"2011","unstructured":"Mitroulis I, et al. (2011) Neutrophil extracellular trap formation is associated with IL-1\u03b2 and autophagy-related signaling in gout. PLoS One. 6:e29318.","journal-title":"PLoS One"},{"key":"2001138_CR15","doi-asserted-by":"publisher","first-page":"R184","DOI":"10.1186\/ar4015","volume":"14","author":"DA Abdulahad","year":"2012","unstructured":"Abdulahad DA, et al. (2012) Urine levels of HMGB1 in systemic lupus erythematosus patients with and without renal manifestations. Arthritis Res. Ther. 14:R184.","journal-title":"Arthritis Res. Ther."},{"key":"2001138_CR16","doi-asserted-by":"publisher","first-page":"584","DOI":"10.3109\/08916934.2012.719946","volume":"45","author":"N Maugeri","year":"2012","unstructured":"Maugeri N, et al. (2012) Circulating platelets as a source of the damage-associated molecular pattern HMGB1 in patients with systemic sclerosis. Autoimmunity. 45:584\u20137.","journal-title":"Autoimmunity"},{"key":"2001138_CR17","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1177\/0961203313483377","volume":"22","author":"DA Abdulahad","year":"2013","unstructured":"Abdulahad DA, et al. (2013) High mobility group box 1 (HMGB1) in relation to cutaneous inflammation in systemic lupus erythematosus (SLE). Lupus. 22:597\u2013606.","journal-title":"Lupus"},{"key":"2001138_CR18","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1007\/s00296-012-2578-y","volume":"33","author":"P Oktayoglu","year":"2013","unstructured":"Oktayoglu P, et al. (2013) Elevated serum levels of high mobility group box protein 1 (HMGB1) in patients with ankylosing spondylitis and its association with disease activity and quality of life. Rheumatol. Int. 33:1327\u201331.","journal-title":"Rheumatol. Int."},{"key":"2001138_CR19","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.3899\/jrheum.120987","volume":"40","author":"H Schierbeck","year":"2013","unstructured":"Schierbeck H, et al. (2013) HMGB1 levels are increased in patients with juvenile idiopathic arthritis, correlate with early onset of disease, and are independent of disease duration. J. Rheumatol. 40:1604\u201313.","journal-title":"J. Rheumatol"},{"key":"2001138_CR20","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1016\/j.jmb.2008.10.001","volume":"384","author":"L Cato","year":"2008","unstructured":"Cato L, Stott K, Watson M, Thomas JO. (2008) The interaction of HMGB1 and linker histones occurs through their acidic and basic tails. J. Mol. Biol. 384:1262\u201372.","journal-title":"J. Mol. Biol."},{"key":"2001138_CR21","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.bbagrm.2009.09.008","volume":"1799","author":"M \u0160tros","year":"2010","unstructured":"\u0160tros M. (2010) HMGB proteins: interactions with DNA and chromatin. Biochim. Biophys. Acta. 1799:101\u201313.","journal-title":"Biochim. Biophys. Acta."},{"key":"2001138_CR22","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1042\/BST20120014","volume":"40","author":"JO Thomas","year":"2012","unstructured":"Thomas JO, Stott K. (2012) H1 and HMGB1: modulators of chromatin structure. Biochem. Soc. Trans. 40:341\u2013346.","journal-title":"Biochem. Soc. Trans."},{"key":"2001138_CR23","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1093\/embo-reports\/kvf198","volume":"3","author":"S Gardella","year":"2002","unstructured":"Gardella S, et al. (2002) The nuclear protein HMGB1 is secreted by monocytes via a non-classical, vesicle-mediated secretory pathway. EMBO Rep. 3:995\u20131001.","journal-title":"EMBO Rep"},{"key":"2001138_CR24","doi-asserted-by":"publisher","first-page":"5551","DOI":"10.1093\/emboj\/cdg516","volume":"22","author":"T Bonaldi","year":"2003","unstructured":"Bonaldi T, et al. (2003) Monocytic cells hyperacetylate chromatin protein HMGB1 to redirect it towards secretion. EMBO J. 22:5551\u201360.","journal-title":"EMBO J."},{"key":"2001138_CR25","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1038\/nature00858","volume":"418","author":"P Scaffidi","year":"2002","unstructured":"Scaffidi P, Misteli T, Bianchi ME. (2002) Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature. 418:191\u20135.","journal-title":"Nature"},{"key":"2001138_CR26","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1038\/sj.embor.7400205","volume":"5","author":"P Rovere-Querini","year":"2004","unstructured":"Rovere-Querini P, et al. (2004) HMGB1 is an endogenous immune adjuvant released by necrotic cells. EMBO Rep. 5:825\u201330.","journal-title":"EMBO Rep"},{"key":"2001138_CR27","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1038\/cdd.2011.96","volume":"19","author":"L Galluzzi","year":"2012","unstructured":"Galluzzi L, et al. (2012) Molecular definitions of cell death subroutines: recommendations of the Nomenclature Committee on Cell Death 2012. Cell Death Differ. 19:107\u201320.","journal-title":"Cell Death Differ."},{"key":"2001138_CR28","doi-asserted-by":"publisher","first-page":"25752","DOI":"10.1074\/jbc.270.43.25752","volume":"270","author":"O Hori","year":"1995","unstructured":"Hori O, et al. (1995) The receptor for advanced glycation end products (RAGE) is a cellular binding site for amphoterin. Mediation of neurite outgrowth and co-expression of rage and amphoterin in the developing nervous system. J. Biol. Chem. 270:25752\u201361.","journal-title":"J. Biol. Chem"},{"key":"2001138_CR29","doi-asserted-by":"publisher","first-page":"7370","DOI":"10.1074\/jbc.M306793200","volume":"279","author":"JS Park","year":"2004","unstructured":"Park JS, et al. (2004) Involvement of toll-like receptors 2 and 4 in cellular activation by high mobility group box 1 protein. J. Biol. Chem. 279:7370\u201377.","journal-title":"J. Biol. Chem"},{"key":"2001138_CR30","doi-asserted-by":"publisher","first-page":"C917","DOI":"10.1152\/ajpcell.00401.2005","volume":"290","author":"JS Park","year":"2006","unstructured":"Park JS, et al. (2006) High mobility group box 1 protein interacts with multiple toll-like receptors. Am. J. Physiol. Cell Physiol. 290:C917\u201324.","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"2001138_CR31","doi-asserted-by":"publisher","first-page":"2184","DOI":"10.1002\/eji.200526066","volume":"35","author":"IE Dumitriu","year":"2005","unstructured":"Dumitriu IE, Baruah P, Bianchi ME, Manfredi AA, Rovere-Querini P. (2005) Requirement of HMGB1 and RAGE for the maturation of human plasmacytoid dendritic cells. Eur. J. Immunol. 35:2184\u201390.","journal-title":"Eur. J. Immunol"},{"key":"2001138_CR32","doi-asserted-by":"publisher","first-page":"1970","DOI":"10.1182\/blood-2006-09-044776","volume":"110","author":"S Ivanov","year":"2007","unstructured":"Ivanov S, et al. (2007) A novel role for HMGB1 in TLR9-mediated inflammatory responses to CpG-DNA. Blood. 110:1970\u201381.","journal-title":"Blood"},{"key":"2001138_CR33","doi-asserted-by":"publisher","first-page":"7021","DOI":"10.1074\/jbc.M108417200","volume":"277","author":"A Dintilhac","year":"2002","unstructured":"Dintilhac A, Bernu\u00e9s J. (2002) HMGB1 interacts with many apparently unrelated proteins by recognizing short amino acid sequences. J. Biol. Chem. 277:7021\u20138.","journal-title":"J. Biol. Chem"},{"key":"2001138_CR34","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1189\/jlb.1008585","volume":"86","author":"ME Bianchi","year":"2009","unstructured":"Bianchi ME. (2009) HMGB1 loves company. J. Leukoc. Biol. 86:573\u20136.","journal-title":"J. Leukoc. Biol."},{"key":"2001138_CR35","doi-asserted-by":"publisher","first-page":"R136","DOI":"10.1186\/ar3450","volume":"13","author":"H W\u00e4h\u00e4maa","year":"2011","unstructured":"W\u00e4h\u00e4maa H, et al. (2011) High mobility group box protein 1 in complex with lipopolysaccharide or IL-1 promotes an increased inflammatory phenotype in synovial fibroblasts. Arthritis Res. Ther. 13:R136.","journal-title":"Arthritis Res. Ther."},{"key":"2001138_CR36","doi-asserted-by":"publisher","first-page":"224","DOI":"10.2119\/molmed.2011.00327","volume":"18","author":"HS Hreggvidsd\u00f3ttir","year":"2012","unstructured":"Hreggvidsd\u00f3ttir HS, et al. (2012) High mobility group box protein 1 (HMGB1)-partner molecule complexes enhance cytokine production by signaling through the partner molecule receptor. Mol. Med. 18:224\u201330.","journal-title":"Mol. Med."},{"key":"2001138_CR37","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1111\/sji.12041","volume":"77","author":"P Leclerc","year":"2013","unstructured":"Leclerc P, et al. (2013) IL-1\u03b2\/HMGB1 complexes promote the PGE2 biosynthesis pathway in synovial fibroblasts. Scand. J. Immunol. 77:350\u201360.","journal-title":"Scand. J. Immunol"},{"key":"2001138_CR38","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1084\/jem.20120189","volume":"209","author":"E Venereau","year":"2012","unstructured":"Venereau E, et al. (2012) Mutually exclusive redox forms of HMGB1 promote cell recruitment or proinflammatory cytokine release. J. Exp. Med. 209:1519\u201328.","journal-title":"J. Exp. Med."},{"key":"2001138_CR39","doi-asserted-by":"publisher","first-page":"250","DOI":"10.2119\/molmed.2011.00389","volume":"18","author":"H Yang","year":"2012","unstructured":"Yang H, et al. (2012) Redox modification of cysteine residues regulates the cytokine activity of high mobility group box-1 (HMGB1). Mol. Med. 18:250\u20139.","journal-title":"Mol. Med."},{"key":"2001138_CR40","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.molimm.2012.10.037","volume":"55","author":"E Venereau","year":"2013","unstructured":"Venereau E, Schiraldi M, Uguccioni M, Bianchi ME. (2013) HMGB1 and leukocyte migration during trauma and sterile inflammation. Mol. Immunol. 55:76\u201382.","journal-title":"Mol. Immunol"},{"key":"2001138_CR41","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1111\/joim.12104","volume":"274","author":"SI Vald\u00e9s-Ferrer","year":"2013","unstructured":"Vald\u00e9s-Ferrer SI, et al. (2013) HMGB1 mediates splenomegaly and expansion of splenic CD11b+ Ly-6C (high) inflammatory monocytes in murine sepsis survivors. J. Intern. Med. 274:381\u201390.","journal-title":"J. Intern. Med."},{"key":"2001138_CR42","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1177\/1753425912437981","volume":"18","author":"C Beyer","year":"2012","unstructured":"Beyer C, et al. (2012) The extracellular release of DNA and HMGB1 from Jurkat T cells during in vitro necrotic cell death. Innate Immun. 18:727\u201337.","journal-title":"Innate Immun."},{"key":"2001138_CR43","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/j.cell.2010.02.014","volume":"140","author":"S Nagata","year":"2010","unstructured":"Nagata S, Hanayama R, Kawane K. (2010) Autoimmunity and the clearance of dead cells. Cell. 140:619\u201330.","journal-title":"Cell"},{"key":"2001138_CR44","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1007\/s10495-010-0478-8","volume":"15","author":"K Kruse","year":"2010","unstructured":"Kruse K, et al. (2010) Inefficient clearance of dying cells in patients with SLE: anti-dsDNA autoantibodies, MFG-E8, HMGB-1 and other players. Apoptosis. 15:1098\u2013113.","journal-title":"Apoptosis"},{"key":"2001138_CR45","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1089\/ars.2012.5143","volume":"20","author":"DS Pisetsky","year":"2014","unstructured":"Pisetsky DS. (2014) The translocation of nuclear molecules during inflammation and cell death. Antioxid. Redox Signal. 20:1117\u201325.","journal-title":"Antioxid. Redox Signal"},{"key":"2001138_CR46","doi-asserted-by":"publisher","first-page":"C1318","DOI":"10.1152\/ajpcell.00616.2005","volume":"291","author":"CW Bell","year":"2006","unstructured":"Bell CW, Jiang W, Reich CF 3rd, Pisetsky DS. (2006) The extracellular release of HMGB1 during apoptotic cell death. Am. J. Physiol. Cell Physiol. 291:C1318\u201325.","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"2001138_CR47","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.immuni.2008.05.013","volume":"29","author":"H Kazama","year":"2008","unstructured":"Kazama H, et al. (2008) Induction of immunological tolerance by apoptotic cells requires caspase-dependent oxidation of high-mobility group box-1 protein. Immunity. 29:21\u201332.","journal-title":"Immunity"},{"key":"2001138_CR48","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1038\/cdd.2008.143","volume":"16","author":"J Thorburn","year":"2009","unstructured":"Thorburn J, et al. (2009) Autophagy regulates selective HMGB1 release in tumor cells that are destined to die. Cell Death Differ. 16:175\u201383.","journal-title":"Cell Death Differ."},{"key":"2001138_CR49","doi-asserted-by":"publisher","first-page":"5299","DOI":"10.1038\/onc.2010.261","volume":"29","author":"D Tang","year":"2010","unstructured":"Tang D, et al. (2010) HMGB1 release and redox regulates autophagy and apoptosis in cancer cells. Oncogene. 29:5299\u2013310.","journal-title":"Oncogene"},{"key":"2001138_CR50","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1080\/08916930902831803","volume":"42","author":"V Urbonaviciute","year":"2009","unstructured":"Urbonaviciute V, et al. (2009) Oxidation of the alarmin high-mobility group box 1 protein (HMGB1) during apoptosis. Autoimmunity. 42:305\u20137.","journal-title":"Autoimmunity"},{"key":"2001138_CR51","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1111\/j.1600-065X.2011.01044.x","volume":"243","author":"EA Miao","year":"2011","unstructured":"Miao EA, Rajan JV, Aderem A. (2011) Caspase-1-induced pyroptotic cell death. Immunol. Rev. 243:206\u201314.","journal-title":"Immunol. Rev."},{"key":"2001138_CR52","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1038\/emboj.2012.328","volume":"32","author":"S Nystr\u00f6m","year":"2013","unstructured":"Nystr\u00f6m S, et al. (2013) TLR activation regulates damage-associated molecular pattern isoforms released during pyroptosis. EMBO J. 32:86\u201399.","journal-title":"EMBO J."},{"key":"2001138_CR53","doi-asserted-by":"publisher","first-page":"4385","DOI":"10.4049\/jimmunol.1000803","volume":"185","author":"M Lamkanfi","year":"2010","unstructured":"Lamkanfi M, et al. (2010) Inflammasome-dependent release of the alarmin HMGB1 in endotoxemia. J. Immunol. 185:4385\u201392.","journal-title":"J. Immunol"},{"key":"2001138_CR54","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1083\/jcb.201203170","volume":"198","author":"V Brinkmann","year":"2012","unstructured":"Brinkmann V, Zychlinsky A. (2012) Neutrophil extracellular traps: is immunity the second function of chromatin? J. Cell Biol. 198:773\u201383.","journal-title":"J. Cell Biol."},{"key":"2001138_CR55","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1038\/nm.1959","volume":"15","author":"K Kessenbrock","year":"2009","unstructured":"Kessenbrock K, et al. (2009) Netting neutrophils in autoimmune small-vessel vasculitis. Nat. Med. 15:623\u20135.","journal-title":"Nat. Med."},{"key":"2001138_CR56","doi-asserted-by":"publisher","first-page":"73ra20","DOI":"10.1126\/scitranslmed.3001201","volume":"3","author":"GS Garcia-Romo","year":"2011","unstructured":"Garcia-Romo GS, et al. (2011) Netting neutrophils are major inducers of Type I IFN production in pediatric systemic lupus erythematosus. Sci. Transl. Med. 3:73ra20.","journal-title":"Sci. Transl. Med."},{"key":"2001138_CR57","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1038\/nm.2847","volume":"18","author":"BG Yipp","year":"2012","unstructured":"Yipp BG, et al. (2012) Infection-induced NETosis is a dynamic process involving neutrophil multitasking in vivo. Nat. Med. 18:1386\u201393.","journal-title":"Nat. Med."},{"key":"2001138_CR58","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1038\/nm.2053","volume":"15","author":"J Xu","year":"2009","unstructured":"Xu J, et al. (2009) Extracellular histones are major mediators of death in sepsis. Nat. Med. 15:1318\u201321.","journal-title":"Nat. Med."},{"key":"2001138_CR59","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.clim.2012.04.006","volume":"144","author":"DS Pisetsky","year":"2012","unstructured":"Pisetsky DS. (2012) The origin and properties of extracellular DNA: from PAMP to DAMP. Clin. Immunol. 144:32\u201340.","journal-title":"Clin. Immunol"},{"key":"2001138_CR60","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1038\/ni1457","volume":"8","author":"J Tian","year":"2007","unstructured":"Tian J, et al. (2007) Toll-like receptor 9-dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE. Nat Immunol. 8:487\u201396.","journal-title":"Nat Immunol"},{"key":"2001138_CR61","doi-asserted-by":"publisher","first-page":"3007","DOI":"10.1084\/jem.20081165","volume":"205","author":"V Urbonaviciute","year":"2008","unstructured":"Urbonaviciute V, et al. (2008) Induction of inflammatory and immune responses by HMGB1-nucleosome complexes: implications for the pathogenesis of SLE. J. Exp. Med. 205:3007\u201318.","journal-title":"J. Exp. Med."},{"key":"2001138_CR62","doi-asserted-by":"publisher","first-page":"5411","DOI":"10.4049\/jimmunol.1203301","volume":"190","author":"Z Wen","year":"2013","unstructured":"Wen Z, et al. (2013) Autoantibody induction by DNA-containing immune complexes requires HMGB1 with the TLR2\/microRNA-155 pathway. J. Immunol. 190:5411\u201322.","journal-title":"J. Immunol"},{"key":"2001138_CR63","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1038\/labinvest.2013.61","volume":"93","author":"W Sun","year":"2013","unstructured":"Sun W, et al. (2013) Immune complexes activate human endothelium involving the cell-signaling HMGB1-RAGE axis in the pathogenesis of lupus vasculitis. Lab. Invest. 93:626\u201338.","journal-title":"Lab. Invest"},{"key":"2001138_CR64","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1093\/intimm\/dxs161","volume":"25","author":"Q Wang","year":"2013","unstructured":"Wang Q, et al. (2013) Pyroptotic cells externalize eat-me and release find-me signals and are efficiently engulfed by macrophages. Int. Immunol. 25:363\u201372.","journal-title":"Int. Immunol"},{"key":"2001138_CR65","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1016\/j.jhep.2011.12.019","volume":"56","author":"DJ Antoine","year":"2012","unstructured":"Antoine DJ, et al. (2012) Molecular forms of HMGB1 and keratin-18 as mechanistic biomarkers for mode of cell death and prognosis during clinical acetaminophen hepatotoxicity. J. Heptaol. 56:1070\u20139.","journal-title":"J. Heptaol"},{"key":"2001138_CR66","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1038\/clpt.2012.40","volume":"92","author":"AH Harrill","year":"2012","unstructured":"Harrill AH, et al. (2012) The effects of heparins on the liver: application of mechanistic serum biomarkers in a randomized study in healthy volunteers. Clin. Pharmacol. Ther. 92:214\u201320.","journal-title":"Clin. Pharmacol. Ther."},{"key":"2001138_CR67","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.pharmthera.2013.11.001","volume":"141","author":"D Musumeci","year":"2013","unstructured":"Musumeci D, Roviello GN, Montesarchio D. (2013) An overview on HMGB1 inhibitors as potential therapeutic agents in HMGB1-related pathologies. Pharmacol. Ther. 141:347\u201357.","journal-title":"Pharmacol. Ther."},{"key":"2001138_CR68","first-page":"706156","volume":"2013","author":"Y Zhou","year":"2013","unstructured":"Zhou Y, et al. (2013) Protective effects of necrostatin-1 against concanavalin A-induced acute hepatic injury in mice. Mediators Inflamm. 2013:706156.","journal-title":"Mediators Inflamm"},{"key":"2001138_CR69","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.immuni.2008.06.006","volume":"29","author":"ME Peter","year":"2008","unstructured":"Peter ME. (2008) ROS eliminate danger. Immunity. 29:1\u20132.","journal-title":"Immunity"},{"key":"2001138_CR70","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/j.cell.2010.02.029","volume":"140","author":"C Nathan","year":"2010","unstructured":"Nathan C, Ding A. (2010) Nonresolving inflammation. Cell. 140:871\u201382.","journal-title":"Cell"}],"container-title":["Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.2119\/molmed.2013.00164.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.2119\/molmed.2013.00164\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.crossref.org\/molmed.2013.00164","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.2119\/molmed.2013.00164.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,6]],"date-time":"2019-04-06T01:21:12Z","timestamp":1554513672000},"score":1,"resource":{"primary":{"URL":"https:\/\/molmed.biomedcentral.com\/articles\/10.2119\/molmed.2013.00164"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1]]},"references-count":70,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,1]]}},"alternative-id":["2001138"],"URL":"https:\/\/doi.org\/10.2119\/molmed.2013.00164","relation":{},"ISSN":["1076-1551","1528-3658"],"issn-type":[{"value":"1076-1551","type":"print"},{"value":"1528-3658","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,1]]}}}